Oriola

1.79EUR -0.56 %

Oriola is a pharmaceutical group with a special focus on the distribution of pharmaceuticals to other companies in the industry. The company offers services to pharmacies and other pharmaceutical companies, which includes, for example, negotiations with suppliers and distribution of products. The largest presence is in the Nordic and Baltic countries. The head office is located in Espoo.

P/E (22e)
15.95
EV/EBIT (22e)
5.12
P/B (22e)
1.32
Dividend yield-% (22e)
2.79 %
Target price
2.30 EUR
Recommendation
Accumulate
Updated
7.8.2022
NASDAQ Helsinki
OKDBV
Daily low / high price
1.79 / 1.826 EUR
Market cap
228.65M EUR
Turnover
45.15K EUR
Volume
25K
Risk and recommendation
HighRiskLow
SellRecommendationBuy
Publisher
Video

Oriola Q2'22 – Friday, Jul. 22 at 10:00 am EEST

Follow Oriola's Q2’22 info on Friday, July 22 at 10:00 am EEST on inderesTV.

2022-06-15
Publisher
Video

Oriola Q1'22 – Thursday, April 28 at 10:00 EEST

Follow Oriola Q1'22 - Thursday, April 28 at 10:00 EEST

2022-04-19
Publisher
Video

Oriola Q4'21 - Friday, Feb. 18 at 10:00 EET

Oriola Financial statements release for 2021 - Friday, Feb. 18 at 10:00 EET

2022-02-09
Publisher
Video

Oriola webcast 9.2.2022 February 9 at 11:00 EET

Oriola webcast 9.2.2022 February 9 at 11:00 EET.

2022-02-09